Replication of immunodeficiency virus in humans

April 16, 2012

Drs. Beatrice Hahn and Frank Kirchoff led an international research effort to understand what adaptations allow a chimpanzee strain of SIV to replicate in human tissues.

The (AIDS) pandemic is caused by the (HIV-1), which attacks the immune system and leaves infected individuals susceptible to opportunistic infections. AIDS and HIV-1 are thought to have a relatively short history in humans, with the first infections likely occurring around the turn of the 20th century.

HIV-1 is derived from highly related simian immunodeficiency viruses (SIVs) that infect modern primates, including chimpanzees. SIVs must have crossed the to infect humans at some point in the past, but the molecular adaptations that permitted a new host are unknown. Drs. Beatrice Hahn and Frank Kirchoff led an international research effort to understand what adaptations allow a chimpanzee strain of SIV to replicate in human tissues.

They found that SIV is capable of replicating in human immune tissues, but that replication occurs at very low levels. By introducing a single amino acid change into the SIV Gag protein, a structural protein that makes up the viral capsid, the research team found that in cultured human tissues increased dramatically, while replication in chimpanzee-derived was decreased.

Their work indicates that species-specific adaptation of Gag is critical for viral replication efficiency and suggests that changes in Gag potentially played a role in the emergence of HIV/AIDS.

Explore further: Antibodies help protect monkeys from HIV-like virus, scientists show

More information: Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation, www.jci.org/articles/view/61429?key=b299fdfbdc1c9633aa06

Related Stories

Recommended for you

Fireflies light the way to female HIV transmission

April 27, 2016

Finding the vulnerable points where HIV enters the female reproductive tract is like searching for needles in a haystack. But Northwestern Medicine scientists have solved that challenge by creating a glowing map of the very ...

HIV can develop resistance to CRISPR/Cas9

April 7, 2016

The CRISPR/Cas9 gene-editing platform may need a little bit more tweaking before it can be used as an effective antiviral, reports a study published April 7 in Cell Reports. Researchers who used CRISPR/Cas9 to mutate HIV-1 ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.